Cadus Financial Ratios

Cadus Corporation -- USA Stock  

USD 1.24  0.01  0.8%

We found twenty-five available fundamental indicators for Cadus Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Cadus fundamentals including its EBITDA as well as the relationship between Cash Flow from Operations and Retained Earnings . Given that Cadus is a hitting penny stock territory we recommend to closely look at its Price to Earning.Use Cadus to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Cadus to be traded at $1.2152 in 30 days

Cadus Company Summary

Cadus competes with ImmunoClin, Amarillo Biosciences, and IBEX Technologies. Cadus Corp purchases individual homes or residential lots for renovation or construction, and resale. As of March 15, 2016, its properties included 12 residential properties in MiamiDade County, Florida and 1 property in East Hampton, New York. Cadus Corp was formerly known as Cadus Pharmaceutical Corporationration and changed its name to Cadus Corporationration in June 2003. Cadus Corporationration was founded in 1992 and is based in New York, New York.

Cadus Working Capital vs Price to Book

Cadus Corporation is rated second overall in working capital category among related companies. It is rated second overall in price to book category among related companies . The ratio of Working Capital to Price to Book for Cadus Corporation is about  67,036,066 

Cadus Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Cadus to competition
FundamentalsCadusPeer Average
Return On Equity(1.8) % (15.17) %
Return On Asset(1.14) % (15.64) %
Current Valuation27.44 M152.14 B
Shares Outstanding26.29 M1.43 B
Shares Owned by Insiders0.09 % 6.91 %
Shares Owned by Institutions67.85 % 18.37 %
Price to Earning(36.54) times40.69 times
Price to Book0.61 times14.44 times
EBITDA(753.28 K)1.41 B
Net Income(736.73 K)517.71 M
Cash and Equivalents4.37 M3.89 B
Cash per Share0.17 times5.17 times
Current Ratio9.19 times3.3 times
Book Value Per Share1.55 times13.64 times
Cash Flow from Operations(3.08 M)1.25 B
Earnings Per Share(0.03) times2.3 times
Number of Employees510.67 K
Beta0.320.34
Market Capitalization31.55 M29.78 B
Total Asset41.5 M126.86 B
Retained Earnings(39.16 M)38.24 B
Working Capital40.89 M3.58 B
Current Asset41.29 M36.8 B
Current Liabilities399 K33.34 B
< 39% 

Chance of Financial Distress

Cadus Corporation has less than 39 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Compare

Compare Cadus To Peers
Hunter Gary CEO and President and Director
David Blitz CFO, Principal Accounting Officer, Treasurer and Secretary
More Executives

Opportunity Range

October 17, 2017 Opportunity Range